UChicago Medicine Comprehensive Cancer Center· @UCCancerCenter · X·· 2 天前评分45
正文 · 原文
At #ESMO26, Randy Sweis, MD, presents interim results from cohort 7 of the phase 1b TROPHY-U-01 trial, testing SG + EV + zimberelimab as first-line treatment for metastatic urothelial cancer. #bladdercancer @RandySweis
376 浏览 · 10 赞 · 5 转发 · 0 回复
会议摘要
4742O按 Proffered paper 1: Genitourinary tumour, renal and urothelial 对上
Sacituzumab Govitecan (SG) Combined With Enfortumab Vedotin (EV) and Zimberelimab (ZIM) in Treatment-Naive Metastatic Urothelial Cancer (mUC): Interim Results From Phase 1b TROPHY-U-01 Cohort 7
https://esmocongress.esmo.org